Dharti Proteins Ltd reported a net loss of ₹0.4568 crore for Q4 FY26, with zero revenue from operations. The company has completed its Corporate Insolvency Resolution Process (CIRP) and is under new management, but faces auditor concerns over internal controls.
Dharti Proteins Completes CIRP, Posts Wider Q4 Loss With Zero Revenue
Net Loss for Q4 FY26: ₹0.4568 crore Net Loss for FY26: ₹4.701 crore Reader Takeaway: Insolvency resolution complete, but zero revenue and auditor control concerns highlight early turnaround stage. ## What just happened Dharti Proteins Limited (formerly Devika Proteins Limited) announced its audited financial results for the fourth quarter and year ended March 31, 2026. The company reported a net loss of ₹0.4568 crore for the quarter, a widening from the previous quarter's ₹0.3422 crore loss. Significantly, the company reported zero revenue from operations for the quarter. For the full year ended March 31, 2026, the cash flow from operations was a negative ₹4.701 crore. The company also completed its Corporate Insolvency Resolution Process (CIRP) under the IBC, with the NCLT approving the resolution plan on November 18, 2025. The company is now under new management led by promoter Mr. Jatinbhai Ramanbhai Patel. ## Why this matters The completion of CIRP marks a significant structural change for Dharti Proteins, signaling a new beginning under new ownership. However, the financial results are concerning, with no operational revenue and a widening loss. This indicates that the business is in a critical transition phase, and the path to operational profitability and revenue generation is yet to begin. The auditor's disclaimer of opinion on the adequacy of internal financial controls is a major red flag for investors. It suggests potential weaknesses in financial reporting processes, which requires close monitoring. ## The backstory Dharti Proteins has been undergoing a significant restructuring following its insolvency. The approval of the resolution plan by the NCLT and the subsequent takeover by a new promoter are key milestones in this process. Historically, companies emerging from CIRP often face challenges in stabilizing operations, rebuilding revenue streams, and establishing robust governance frameworks. ## What changes now With the CIRP concluded, the focus shifts entirely to operational revival and financial performance under the new management. Investors will be closely watching for any signs of revenue generation, cost management, and improvements in internal financial controls. The company also needs to manage legacy issues, such as statutory dues that continue to appear on portals despite being accounted for. ## Risks to watch * **Operational Turnaround:** The primary risk is the company's ability to restart operations and generate revenue. Zero revenue indicates this is a significant challenge. * **Internal Control Weaknesses:** The auditor's disclaimer of opinion on internal financial controls presents a governance risk and potential for financial misstatements. * **Legacy Liabilities:** Managing outstanding statutory dues and government demands, even if accounted for, can pose ongoing challenges. * **Cash Burn:** Negative cash flow from operations suggests a continued need for funding or a drain on existing resources. ## Peer comparison Detailed peer comparison is difficult without specific operational and financial data from comparable companies that have recently emerged from CIRP. However, companies in the edible oil or protein processing sector typically rely on stable raw material sourcing and consistent sales to maintain profitability. Dharti Proteins' current zero-revenue status places it in a unique, high-risk category among its peers. ## Context metrics (time-bound) * **Net Loss (Q4 FY26):** ₹0.4568 crore * **Net Loss (Q3 FY26):** ₹0.3422 crore * **Revenue (Q4 FY26):** ₹0 crore * **Paid-up Equity Capital (as of March 31, 2026):** ₹0.50 crore * **Cash Flow from Operations (FY26):** ₹-4.701 crore * **Cash Flow from Financing (FY26):** ₹0.3169 crore ## What to track next Investors should closely monitor future quarterly results for any indication of revenue generation and operational progress. The company's response to the auditor's disclaimer on internal controls and its strategy for addressing legacy statutory dues will be critical.
Get stock alerts instantly on WhatsApp
Quarterly results, bulk deals, concall updates and major announcements delivered in real time.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.
